Vyepti® (eptinezumab) is a quarterly intravenous treatment designed to prevent migraines before they begin. Unlike daily medications or monthly injections, Vyepti is administered only four times per year and targets CGRP, a key migraine signaling molecule. Learn how this innovative therapy works, who may qualify, what side effects to consider, and the insurance steps often required before treatment can begin. This guide reviews the benefits, risks, and practical consideration

Popular GLP-1 medications, like Ozempic and Zepbound may provide prevention of Alzheimer's Dementia on top of the weight reduction and diabetes control. Reduction of weight helps with Sleep Apnea, as well. Understand the need for medical monitoring if you are going to use these medications. This is a worthy read to give a comprehensive presentation as to the risks/benefits as well as the need for vigilance.

An interesting article that may enlighten us as to what might be going wrong leading to dementia.